Unprecedented Citrinin Trimer Tricitinol B Functions as a Novel Topoisomerase IIα Inhibitor

被引:53
作者
Du, Lin [1 ]
Liu, Hong-Chun [2 ]
Fu, Wei [3 ]
Li, De-Hai [1 ]
Pan, Qiu-Ming [2 ]
Zhu, Tian-Jiao [1 ]
Geng, Mei-Yu [2 ]
Gu, Qan-Qun [1 ]
机构
[1] Ocean Univ China, Sch Med & Pharm, Minist Educ China, Key Lab Marine Drugs, Qingdao 266003, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China
[3] Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai 201203, Peoples R China
关键词
MOLECULAR-MECHANISMS; DNA CLEAVAGE; SOLID-STATE; DRUGS; APOPTOSIS; TARGET; DECOMPOSITION; ASSAY;
D O I
10.1021/jm200511x
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Fifteen citrinin derivatives (1-4,6-16), including two unprecedented citrinin timers tricitrinols A (3) and B (4), were isolated from Penicillium citrinum HGY1-5. The six-membered ring A system is essential for the cytotoxicity of active dimers (1, 2, and 5) and trimers (3 and 4). Tricitrinol B (4) showed extensive cytotoxicity in 17 tumor cells with comparable low-micromolar IC50 values (1-10 mu M) and potential antimultidrug resistance capabilities. Tricitrinol B (4) induced cell apoptosis in HL60 and HCT116 cells via mainly extrinsic pathways and G2/M arrest. Further antitumor mechanism study and computational docking analysis indicated that tricitrinol B (4) works as an intercalating topoisomerase II alpha (topo II alpha) poison, which inhibits the enzyme activity of topo II alpha by interfering predominantly with the topo II alpha-mediated poststrand-passage deavage/religation equilibrium over with the prestrand-passage one and induced DNA damage. Tricitrinol B (4) represents a novel class of topo II alpha-inhibitory skeletons for developing new chemotherapeutic agents.
引用
收藏
页码:5796 / 5810
页数:15
相关论文
共 54 条
[1]
A screen of yeast respiratory mutants for sensitivity against the mycotoxin citrinin identifies the vacuolar ATPase as an essential factor for the toxicity mechanism [J].
Ammar, H ;
Michaelis, G ;
Lisowsky, T .
CURRENT GENETICS, 2000, 37 (05) :277-284
[2]
Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies [J].
Azarova, Anna M. ;
Lyu, Yi Lisa ;
Lin, Chao-Po ;
Tsai, Yuan-Chin ;
Lau, Johnson Yiu-Nam ;
Wang, James C. ;
Liu, Leroy F. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (26) :11014-11019
[3]
THE STRUCTURE OF CITRININ INVIVO [J].
BARBER, J ;
CORNFORD, JL ;
HOWARD, TD ;
SHARPLES, D .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1987, (12) :2743-2744
[4]
Molecular mechanisms of anthracycline activity [J].
Beretta, Giovanni Luca ;
Zunino, Franco .
ANTHRACYCLINE CHEMISTRY AND BIOLOGY II: MODE OF ACTION, CLINICAL ASPECTS AND NEW DRUGS, 2008, 283 :1-19
[5]
Betina V, 1989, MYCOTOXINS CHEM BIO
[6]
CHARACTERIZATION OF MONASCIDIN-A FROM MONASCUS AS CITRININ [J].
BLANC, PJ ;
LAUSSAC, JP ;
LEBARS, J ;
LEBARS, P ;
LORET, MO ;
PAREILLEUX, A ;
PROME, D ;
PROME, JC ;
SANTERRE, AL ;
GOMA, G .
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 1995, 27 (2-3) :201-213
[7]
Intercalators as anticancer drugs [J].
Braña, MF ;
Cacho, M ;
Gradillas, A ;
de Pascual-Teresa, B ;
Ramos, A .
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (17) :1745-1780
[8]
Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme [J].
Burden, DA ;
Osheroff, N .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :139-154
[9]
MECHANISM OF CITRININ-INDUCED DYSFUNCTION OF MITOCHONDRIA .3. EFFECTS ON RENAL CORTICAL AND LIVER MITOCHONDRIAL SWELLING [J].
CHAGAS, GM ;
OLIVEIRA, MBM ;
CAMPELLO, AP ;
KLUPPEL, MLW .
JOURNAL OF APPLIED TOXICOLOGY, 1995, 15 (02) :91-95
[10]
Citrinin revisited: from monomers to dimers and beyond [J].
Clark, BR ;
Capon, RJ ;
Lacey, E ;
Tennant, S ;
Gill, JH .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2006, 4 (08) :1520-1528